The Hematologist

July August 2015 Vol 12 Issue 4

July-August 2015, Volume 12, Issue 4

 

Features

  • Program Genealogies: Myeloma at MayoJune 11, 2015

    Dr. Rajkumar discusses how Dr. Robert Kyle started and developed the Multiple Myeloma Program at the Mayo Clinic. Dr. Kyle reflects on the success of the program for over 50 years.

  • Therapy-Related AML and MDS: Who Really Has It?June 05, 2015

    Drs. Gale, Bennett, and Hoffman discuss factors hematologists must keep in mind when diagnosing patients with therapy-related AML or MDS, in order to prevent incorrect therapy decisions.

  • Health-related Smartphone Apps: Status Update for Hem-Onc PractitionersJune 03, 2015

    Drs. Badawy, Liem, and Thompson discuss several benefits, risks, and limitations of using health-related apps, focusing on hematology and oncology apps. They present a thorough study that includes recommendations of some of the best apps available, and a discussion of clinical benefits, cost-effectiveness, potential risks, and even legal concerns.

back to top

Diffusion

back to top

Ask the Hematologist

back to top

Clinical Trials Corner

back to top

Profiles

  • Aaron J. Marcus, MD (1925-2015)June 11, 2015

    Dr. Weksler and James Marcus celebrate the life of Dr. Aaron J. Marcus in this In Memoriam; they discuss his career in the field of hematology, his work as a mentor, and his vast knowledge in several other subjects.

  • Gerald J. Robbins, MD (1951-2015)June 11, 2015

    Drs. Allen and Solberg talk about the life, legacy, and dedication of Dr. Gerald J. Robbins, in this In Memoriam piece, calling him an "irreplaceable friend."

back to top

President's Column

  • ASH as a Global OrganizationJune 11, 2015 | David A. Williams, MD

    Dr. Williams discusses ASH's international presence through various programs and initiatives; he highlights the need for support for several changes in governance and membership structure to help ASH advance as a global organization.

back to top